| human papillomavirus testing with pap triage for cervical cancer prevention in canada: a cost-effectiveness analysis. | recently published results from a large randomized trial (canadian cervical cancer screening trial study group) suggest that human papillomavirus testing followed by pap smear-based triage for human papillomavirus positive women may be an effective way to screen women for cervical cancer. we determined the potential cost-effectiveness of including human papillomavirus tests for cervical cancer screening for canada and three provinces: alberta, newfoundland and ontario. | 2009 | 19900264 |
| inclusion and exclusion in mid-life lesbians' experiences of the pap test. | lesbians are said to feel excluded by sexual health messages that presume heterosexuality, a finding linked to lower levels of papanicolaou (pap) testing. this paper discusses a small, focused qualitative study based in calgary, canada that illuminated mid-life lesbians' experiences and perceptions of pap testing and health. participants indicated that they felt compelled and invited to access pap testing by an inclusive discourse - that of 'mid-life', a period associated with an increased need ... | 2010 | 20721767 |
| oropharyngeal squamous cell carcinoma and human papillomavirus-associated cancers in women: epidemiologic evaluation of association. | human papillomavirus (hpv) is a well-established etiologic factor in oropharyngeal squamous cell carcinoma (opscc). the objective of this study was to evaluate the association between opscc and hpv-related cancerous lesions of the cervix. | 2011 | 21453664 |
| Comparison of the Hybrid Capture 2 and cobas 4800 Tests for Detection of High-Risk Human Papillomavirus in Specimens Collected in PreservCyt Medium. | Clinical cervical cytology specimens (n = 466) collected in PreservCyt (Hologic Inc.) were used to evaluate the agreement between Hybrid Capture 2 (hc2; Qiagen) and cobas 4800 (c4800; Roche Molecular Diagnostics) for the detection of high-risk human papillomavirus (HR HPV) genotype infections. The agreement between the two assays was 93.8% (kappa = 0.87; 95% confidence interval, 0.828 to 0.918), with 186 and 251 concordant positive and negative results, respectively. All 186 concordant positives ... | 2012 | 22090403 |
| effect of human papillomavirus vaccination on cervical cancer screening in alberta. | a school-based program with quadrivalent human papillomavirus (hpv) vaccination was implemented in alberta in 2008. we assessed the impact of this program on pap test cytology results using databases of province-wide vaccination and cervical cancer screening. | 2016 | 27378467 |
| adverse events following hpv vaccination, alberta 2006-2014. | in canada, private purchase of human papilloma virus (hpv) vaccines has been possible since 2006. in alberta, canada, a publicly funded quadrivalent hpv vaccine program began in the 2008/2009 school year. there have been concerns about adverse events, including venous thromboembolism (vte) associated with hpv vaccines. we describe the frequencies of adverse events following hpv vaccination among alberta females aged 9 years or older and look at vte following hpv vaccination. | 2016 | 26921782 |
| social equity in human papillomavirus vaccination: a natural experiment in calgary canada. | the alberta immunization program offers a vaccine against the human papillomavirus (hpv) free of charge to all girls in grades 5 and 9. the vaccine is provided in two different service delivery models depending upon the acceptance of the program by the local school board. vaccinations may be provided "in-school" or in "community" through appointments at public health clinics. the purpose of this study was to determine whether there was a difference in vaccine uptake in calgary between the two se ... | 2013 | 23837819 |
| citizen intervention in a religious ban on in-school hpv vaccine administration in calgary, canada. | in 2008, alberta roman catholic bishops' discouraged in-school hpv vaccination because: "a school-based approach to vaccination sends a message that early sexual intercourse is allowed, as long as one uses 'protection.'" the publicly funded calgary catholic school district board voted against in-school hpv vaccine administration. in 2009, vaccine uptake was 70% in calgary public schools and 18.9% in calgary catholic schools. to physician-citizens who requested in-school vaccination, the elected ... | 2013 | 23769899 |
| primary treatment for oropharyngeal squamous cell carcinoma in alberta, canada: a population-based study. | the incidence of human papillomavirus (hpv)-related oropharyngeal squamous cell carcinoma (scc) is increasing and has better survival than non-hpv related oropharyngeal scc. this study compared surgical to nonsurgical treatments and demographic, clinical, and survival differences in patients with oropharyngeal scc, stratified by p16 status. | 2017 | 28782304 |